Quest Diagnostics Incorporated (NYSE:DGX) stock has seen a rise as of late. Shares have hit a new 52-week high after reaching $93.27 during recent trading action. Investors will be watching to see if the name can maintain momentum heading into the new year.
Share Performance Summary
Since the start of the calendar year, Quest Diagnostics Incorporated (NYSE:DGX)’s stock has changed 1.99%. Over the last five trading sessions, the stock has moved 0.70%. For the past month, Quest Diagnostics Incorporated’s stock has been 2.84%, 12.50% for the last quarter, 13.33% for the past six months and 39.46% for the past 52 weeks.
Based on current stock levels, Quest Diagnostics Incorporated shares are trading 0.17% off of the 50-day high and 18.46% away from the 50-day low.
Earnings Per Share (EPS), the portion of a company’s profit distributed to each outstanding common share, is a useful indicator of a company’s profitability. EPS is typically considered to be the most important variable in determining a share’s price. Quest Diagnostics Incorporated (NYSE:DGX)’s EPS growth this year is 28.60% and the trailing 12-month EPS is $4.72. Covering sell-side analysts are estimating company growth for next year to be 6.98%. On a consensus basis, analysts have given a recommendation of 2.90 on company shares.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.